… trial was opened at The University of Texas MD Anderson Cancer Center in 1993. This was
… doses for prostate cancer. Previously reported results of this study supported dose escalation …

… of prostate cancer, the current prevailing hypothesis centers on delivering higher doses to the
… by increasing the radiation dose in the intermediate-risk group of prostate cancer patients, …

… In conclusion, dose escalation on this multi-institutional phase I trial focusing on acute
toxicity (< 90 days from completion of therapy) in patients with localized prostate cancer was …

… prostate adenocarcinoma and its propensity for late biochemical or clinical failures, the true
benefit, if any, of radiation dose escalation … the value of dose escalation for prostate cancer. …

… the value of dose escalation in optimizing the radiation treatment of prostate cancer. Methods
… Dose was escalated from 68 Gy to 79 Gy. Patient status is reported at 3 years follow-up, …

… study dose escalation for patients with PSA >10 ng/mL or high-risk disease was shown to
provide significant benefit in biochemical and clinical outcome as well as in prostate cancer–…

… This study suggests that prostate cancer control with dose escalation with RT follows a
sigmoidal dose–response curve. An increase in BED to 200 Gy (at α/β of 1.5) was associated with …

… a significant effect of dose escalation on the response of human prostate cancer to irradiation
… evaluate the paradigm of dose escalation in prostate cancer. Dose escalation with 3D-CRT …

… Other studies have shown that dose escalation is possible using conformal techniques …
trials evaluating dose escalation for prostate cancer patients treated in the prostate-specific …

… In this study, late morbidity after high-dose RT for localized prostate cancer was in line with
the experience from other dose-escalation trials 3, 5, 7, 8. The cumulative incidence of late …